Rising Prevalence Of Chronic Diseases Across The Globe Is Fuelling The Global Auto Injectors Market

According to a recently published report, the Auto Injectors Market is growing with the CAGR of 19.2% and the revenue is estimated to grow around $3550 million during the forecast period of 2016-2022. The segmentation of global auto injectors market is based on therapeutic application, types and geography. The report on global auto injectors market forecast, 2016-2022 (by therapeutic application, types and geography) provides detailed overview and predictive analysis of the market.

Full report available global auto injectors market forecast, 2016-2022 (by therapeutic application, types and geography) report at http://www.briskinsights.com/report/auto-injectors-market

Rising prevalence of chronic diseases across the globe is anticipated to boost the global auto injectors market. There has been a significant rise in the prevalence of chronic diseases across the globe. The chronic diseases such as diabetes, chronic respiratory diseases, cancer, stroke and heart disease are the leading cause of death in the world, indicating 60% of all mortality rates. Generally, 80% of deaths caused due to chronic diseases occur in low and middle income countries. According to National Cancer Institute, in 2014, the number of persons who diagnosed cancer had reached to 14.5 million and it is forecasted to increase and reach almost 19 million by the year 2024. According to WHO data on diabetes, the number of persons who are diabetic was 422 million in 2014, which was very high as compared to 1980 and it is also estimated that diabetes will be the 7th main cause of death by 2030.

Auto injectors have a major role in the treatment of chronic diseases. It has been used for the treatment of chronic diseases for many years. For the treatment of chronic diseases, there is a need of frequent injections such as rheumatoid arthritis and multiple sclerosis, the usage and concept of an auto injector is yet quite new to many patients and even it is new for some healthcare professionals. Many new biologics recently has been approved and soon will be launched in the market. It is generally required that biopharmaceutical companies give training equipment that can enable proper self-administration for patients, who are utilizing these devices for the first time. Thus, rising chronic diseases is boosting the demand for the auto injectors market.

Scope of the Report

1. Global Auto Injectors Market By Therapeutic Application 2012 - 2022 ($ Million)
1.1. RHEUMATOID ARTHRITIS
1.2. MULTIPLE SCLEROSIS
1.3. ANAPHYLAXIS
1.4. OTHERS

2. Global Auto Injectors Market By Types 2012-2022 ($ Million)
2.1. Fillable auto injectors
2.2. Prefilled auto injectors
2.3. OTHERS

3. Global Auto Injectors Market Regional Outlook 2012-2022($ Million)
3.1. North America
3.2. Europe
3.3. Asia Pacific
3.4. Middle East & Africa
3.5. Latin America

4. Company Profiles
4.1. Amedra Pharmaceuticals LLC,
4.2. Antares Pharma, Inc.,
4.3. Becton, Dickinson and Company,
4.4. Biogen Idec, Inc.,
4.5. Epipens,
4.6. Mylan, Inc.
4.7. Novartis International AG,
4.8. Owen Mumford and
4.9. PA Consulting Group
4.10. Pfizer, Inc.,
4.11. Rebiject,
4.12. Sanofi
4.13. SHL Group
4.14. Unilife Corporation
4.15. Ypsomed Holdings AG